Clémence Tropis holds a Doctor of Pharmacy degree (PharmD), earned in 2022 and completed a PhD in Pharmacology in 2023 at the University of Toulouse, where her research focused on cognitive impairments associated with surgery-induced inflammation in the context of obesity. In September 2024, she joined the Neuroinflammation Group at the LCSB to investigate the role of central inflammation in the disruption of the blood–brain barrier in Alzheimer’s disease. Her research interests lie in understanding the links between the hallmarks of inflammation and neurodegenerative diseases onset